The effects of Shaoma Zhijing granules and its main components on Tourette syndrome.

Autor: Zhao Q; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China., Hu Y; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China., Yan Y; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China., Song X; State Key Laboratory of Component-based Chinese Medicine, Research Center of Traditional Chinese Medicine, Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China., Yu J; State Key Laboratory of Component-based Chinese Medicine, Research Center of Traditional Chinese Medicine, Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China., Wang W; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China., Zhou S; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China., Su X; Tasly Pharmaceuticals Inc., Rockville, MD 20850, USA., Bloch MH; Yale Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA., Leckman JF; Yale Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: james.leckman@yale.edu., Chen Y; State Key Laboratory of Component-based Chinese Medicine, Research Center of Traditional Chinese Medicine, Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China. Electronic address: chenyb@tjutcm.edu.cn., Sun H; Tasly Pharmaceutical Group Co., Ltd., Tianjin, 300410, China; National Key Laboratory of Chinese Medicine Modernization. Tianjin 300193, China; Tasly Pharmaceuticals Inc., Rockville, MD 20850, USA. Electronic address: henry@tasly.com.
Jazyk: angličtina
Zdroj: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Jul; Vol. 129, pp. 155686. Date of Electronic Publication: 2024 Apr 26.
DOI: 10.1016/j.phymed.2024.155686
Abstrakt: Background: Tourette syndrome (TS) represents a neurodevelopmental disorder characterized by an uncertain etiology and influencing factors. Frequently, it co-occurs with conditions such as attention deficit hyperactivity disorder, obsessive-compulsive disorder, and sleep disturbances, which have garnered substantial attention from the research community in recent years. Clinical trials have demonstrated that Shaoma Zhijing Granules (SMZJG, 5-ling granule, also known as TSupport or T92 under U.S. development), a traditional Chinese medicine compound, is an effective treatment for TS.
Purpose: To conduct scientometric analysis on developing trends, research countries and institutions, current status, hot spots of TS and discuss the underlying mechanisms of SMZJG and its main components on TS. The aim is to provide valuable reference for ongoing clinical and basic research on TS and SMZJG.
Study Design & Methods: Using Tourette syndrome, SMZJG and its main components along with their synonyms as keywords, we conducted a comprehensive search across major scientific databases including the Web of Science Core Collection, PubMed and China National Knowledge Infrastructure (CNKI) databases. A total of 5952 references and 99 patents were obtained. Among these, 5039 articles and reviews, as well as 54 patents were analyzed by Citespace and VOSviewer software.
Results: The available evidence indicates that the SMZJG's components likely exert their mechanisms in treating TS by regulating the dopaminergic pathway system, neurotransmitter imbalances, reducing neuroinflammation, promoting the repair of nerve damage and improving sleep disorders.
Conclusion: This comprehensive analysis lays the foundation for an extensive exploration of the feasibility and clinical applications of SMZJG in TS treatment.
Competing Interests: Declaration of competing interest The authors have no conflicts of interest regarding the publication of this paper.
(Copyright © 2024. Published by Elsevier GmbH.)
Databáze: MEDLINE
Externí odkaz: